Rapha Capital Leads New $3 Million Convertible Note Financing in Imagin Medical, Inc.
Summary
• Rapha Capital will be granted a preemptive right to participate in any future financing undertaken by Imagin, so as to maintain its percentage equity interest. Previously, RCBVFI has invested in FIZE Medical, Inc. (https://fizemedical.com), headquartered in Modiin, Israel that is developing a state-of-the-art platform of assays to measure, in real time, key indicators of the health status of patients found in their urine. Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The Company believes its first product, the i/Blue™ Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information.